|
1
|
Santos RP, Pereira A, Guedes H, Lourenço
C, Azevedo J and Pinto P: Anabolic drugs and myocardial
infarction-a clinical case report. Arq Bras Cardiol. 105:316–319.
2015.PubMed/NCBI View Article : Google Scholar : (In English,
Portuguese).
|
|
2
|
Stergiopoulos K, Brennan JJ, Mathews R,
Setaro JF and Kort S: Anabolic steroids, acute myocardial
infarction and polycythemia: A case report and review of the
literature. Vasc Health Risk Manag. 4:1475–1480. 2008.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Luijkx T, Velthuis BK, Backx FJ, Buckens
CF, Prakken NH, Rienks R, Mali WP and Cramer MJ: Anabolic
androgenic steroid use is associated with ventricular dysfunction
on cardiac MRI in strength trained athletes. Int J Cardiol.
167:664–668. 2013.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Kersey RD, Elliot DL, Goldberg L, Kanayama
G, Leone JE, Pavlovich M and Pope HG Jr: National Athletic
Trainers' Association. National athletic trainers' association
position statement: Anabolic-androgenic steroids. J Athl Train.
47:567–588. 2012.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Christou GA, Christou KA, Nikas DN and
Goudevenos JA: Acute myocardial infarction in a young bodybuilder
taking anabolic androgenic steroids: A case report and critical
review of the literature. Eur J Prev Cardiol. 23:1785–1796.
2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Peoples K, Kobe D, Campana C and Simon E:
Hyperhomocysteinemia-induced myocardial infarction in a young male
using anabolic steroids. Am J Emerg Med. 32:948.e1–2.
2014.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Ilhan E, Demirci D, Güvenç TS and Calık
AN: Acute myocardial infarction and renal infarction in a
bodybuilder using anabolic steroids. Turk Kardiyol Dern Ars.
38:275–278. 2010.PubMed/NCBI
|
|
8
|
Wysoczanski M, Rachko M and Bergmann SR:
Acute myocardial infarction in a young man using anabolic steroids.
Angiology. 59:376–378. 2008.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Hartgens F, Rietjens G, Keizer HA, Kuipers
H and Wolffenbuttel BH: Effects of androgenic-anabolic steroids on
apolipoproteins and lipoprotein (a). Br J Sports Med. 38:253–259.
2004.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Fineschi V, Riezzo I, Centini F,
Silingardi E, Licata M, Beduschi G and Karch SB: Sudden cardiac
death during anabolic steroid abuse: Morphologic and toxicologic
findings in two fatal cases of bodybuilders. Int J Legal Med.
121:48–53. 2007.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Kennedy MC, Corrigan AB and Pilbeam ST:
Myocardial infarction and cerebral haemorrhage in a young body
builder taking anabolic steroids. Aust N Z J Med.
23(713)1993.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Lyngberg KK: Myocardial infarction and
death of a body builder after using anabolic steroids. Ugeskr
Laeger. 153:587–588. 1991.PubMed/NCBI(In Danish).
|
|
13
|
Pilo R, Aharony D and Raz A: Testosterone
potentiation of ionophore and ADP induced platelet aggregation:
Relationship to arachidonic acid metabolism. Thromb Haemost.
46:538–542. 1981.PubMed/NCBI
|
|
14
|
Kokkonen L, Anttonen O, Penttilä O and
Voutilainen S: Protein C deficiency and use of anabolic steroids
behind the myocardial infarction in a young man. Duodecim.
117:2279–2281. 2001.PubMed/NCBI(In Finnish).
|
|
15
|
Buttner A, Sachs H, Mall G, Tutsch-Bauer E
and Weis S: Progressive idiopathic bilateral
striato-pallido-dentate calcinosis (Fahr's disease) in a person
with anabolic steroid abuse. Leg Med (Tokyo). 3:114–118.
2001.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Sonmez E, Turkdogan KA, Yilmaz C,
Kucukbuzcu S, Ozkan A and Sogutt O: Chronic anabolic androgenic
steroid usage associated with acute coronary syndrome in
bodybuilder. Turk J Emerg Med. 16:35–37. 2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Skogastierna C, Hotzen M, Rane A and
Ekström L: A supraphysiological dose of testosterone induces nitric
oxide production and oxidative stress. Eur J Prev Cardiol.
21:1049–1054. 2014.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Tischer KH, Heyny-von Haussen R, Mall G
and Doenecke P: Coronary thrombosis and ectasia of coronary
arteries after long-term use of anabolic steroids. Z Kardiol.
92:326–331. 2003.PubMed/NCBI View Article : Google Scholar : (In German).
|
|
19
|
Phillis BD, Abeywardena MY, Adams MJ,
Kennedy JA and Irvine RJ: Nandrolone potentiates arrhythmogenic
effects of cardiac ischemia in the rat. Toxicol Sci. 99:605–611.
2007.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Sculthorpe N, Grace F, Jones P and Davies
B: Evidence of altered cardiac electrophysiology following
prolonged androgenic anabolic steroid use. Cardiovasc Toxicol.
10:239–243. 2010.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Maior AS, Carvalho AR, Marques-Neto SR,
Menezes P, Soares PP and Nascimento JH: Cardiac autonomic
dysfunction in anabolic steroid users. Scand J Med Sci Sports.
23:548–555. 2013.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Kasikcioglu E, Oflaz H, Umman B and Bugra
Z: Androgenic anabolic steroids also impair right ventricular
function. Int J Cardiol. 134:123–125. 2009.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Frati P, Busardò FP, Cipolloni L,
Dominicis ED and Fineschi V: Anabolic androgenic steroid (AAS)
related deaths: Autoptic, histopathological and toxicological
findings. Curr Neuropharmacol. 13:146–159. 2015.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Gheshlaghi F, Piri-Ardakani MR, Masoumi
GR, Behjati M and Paydar P: Cardiovascular manifestations of
anabolic steroids in association with demographic variables in body
building athletes. J Res Med Sci. 20:165–168. 2015.PubMed/NCBI
|
